|
Name |
1,1,3,3,5,5,7,7,9,9,11,11,13,13-Tetradecamethylheptasiloxane
|
Molecular Formula | C14H42O6Si7 | |
IUPAC Name* |
NA
|
|
SMILES |
C[Si](C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)C
|
|
InChI |
InChI=1S/C14H42O6Si7/c1-21(2)15-23(5,6)17-25(9,10)19-27(13,14)20-26(11,12)18-24(7,8)16-22(3)4/h1-14H3
|
|
InChIKey |
JJIDUNHDYJESJA-UHFFFAOYSA-N
|
|
Synonyms |
19095-23-9; 1,1,3,3,5,5,7,7,9,9,11,11,13,13-Tetradecamethylheptasiloxane; Heptasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13-tetradecamethyl-; AC1LB8OT; SCHEMBL9004474; DTXSID70339091; MFCD30721597; T3548; 1,1,3,3,5,5,7,7,9,9,11,11,13,13-tetradecamethyl-h eptasiloxane; 1,1,3,3,5,5,7,7,9,9,11,11,13,13-Tetradecamethylheptasiloxane #; 2,4,4,6,6,8,8,10,10,12,12,14-dodecamethyl-3,5,7,9,11,13-hexaoxa-2,4,6,8,10,12,14-heptasilapentadecane
|
|
CAS | 19095-23-9 | |
PubChem CID | 6329088 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 503.07 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 6 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 55.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 27 | QED Weighted: | 0.332 |
Caco-2 Permeability: | -5.824 | MDCK Permeability: | 0.00006060 |
Pgp-inhibitor: | 0.096 | Pgp-substrate: | 0.757 |
Human Intestinal Absorption (HIA): | 0.991 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 111.82% |
Volume Distribution (VD): | 3.45 | Fu: | 18.88% |
CYP1A2-inhibitor: | 0.234 | CYP1A2-substrate: | 0.971 |
CYP2C19-inhibitor: | 0.853 | CYP2C19-substrate: | 0.97 |
CYP2C9-inhibitor: | 0.863 | CYP2C9-substrate: | 0.963 |
CYP2D6-inhibitor: | 0.026 | CYP2D6-substrate: | 0.936 |
CYP3A4-inhibitor: | 0.515 | CYP3A4-substrate: | 0.094 |
Clearance (CL): | 2.544 | Half-life (T1/2): | 0.322 |
hERG Blockers: | 0.453 | Human Hepatotoxicity (H-HT): | 0.004 |
Drug-inuced Liver Injury (DILI): | 0.014 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.215 |
Skin Sensitization: | 0.771 | Carcinogencity: | 0.022 |
Eye Corrosion: | 1 | Eye Irritation: | 0.998 |
Respiratory Toxicity: | 0.032 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001783 | 0.870 | D06IGU | 0.101 | ||||
ENC001785 | 0.851 | D0H2DQ | 0.099 | ||||
ENC000373 | 0.586 | D0Z1ZM | 0.097 | ||||
ENC000530 | 0.422 | D06ZUP | 0.094 | ||||
ENC001271 | 0.364 | D03HJK | 0.091 | ||||
ENC003080 | 0.320 | D02YIZ | 0.087 | ||||
ENC001404 | 0.261 | D04JMQ | 0.086 | ||||
ENC003081 | 0.257 | D06EEL | 0.084 | ||||
ENC001122 | 0.247 | D0L2UN | 0.080 | ||||
ENC001182 | 0.245 | D07DIM | 0.079 |